Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer
- PMID: 33771855
- DOI: 10.1158/1078-0432.CCR-20-4217
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer
Abstract
Purpose: Multiparametric MRI (mpMRI) has become an indispensable radiographic tool in diagnosing prostate cancer. However, mpMRI fails to visualize approximately 15% of clinically significant prostate cancer (csPCa). The molecular, cellular, and spatial underpinnings of such radiographic heterogeneity in csPCa are unclear.
Experimental design: We examined tumor tissues from clinically matched patients with mpMRI-invisible and mpMRI-visible csPCa who underwent radical prostatectomy. Multiplex immunofluorescence single-cell spatial imaging and gene expression profiling were performed. Artificial intelligence-based analytic algorithms were developed to examine the tumor ecosystem and integrate with corresponding transcriptomics.
Results: More complex and compact epithelial tumor architectures were found in mpMRI-visible than in mpMRI-invisible prostate cancer tumors. In contrast, similar stromal patterns were detected between mpMRI-invisible prostate cancer and normal prostate tissues. Furthermore, quantification of immune cell composition and tumor-immune interactions demonstrated a lack of immune cell infiltration in the malignant but not in the adjacent nonmalignant tissue compartments, irrespective of mpMRI visibility. No significant difference in immune profiles was detected between mpMRI-visible and mpMRI-invisible prostate cancer within our patient cohort, whereas expression profiling identified a 24-gene stromal signature enriched in mpMRI-invisible prostate cancer. Prostate cancer with strong stromal signature exhibited a favorable survival outcome within The Cancer Genome Atlas prostate cancer cohort. Notably, five recurrences in the 8 mpMRI-visible patients with csPCa and no recurrence in the 8 clinically matched patients with mpMRI-invisible csPCa occurred during the 5-year follow-up post-prostatectomy.
Conclusions: Our study identified distinct molecular, cellular, and structural characteristics associated with mpMRI-visible csPCa, whereas mpMRI-invisible tumors were similar to normal prostate tissue, likely contributing to mpMRI invisibility.
©2021 American Association for Cancer Research.
Similar articles
-
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair Analysis.Prostate. 2025 Mar;85(4):374-384. doi: 10.1002/pros.24838. Epub 2024 Dec 12. Prostate. 2025. PMID: 39665170 Free PMC article.
-
Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.J Hematol Oncol. 2022 May 3;15(1):48. doi: 10.1186/s13045-022-01268-6. J Hematol Oncol. 2022. PMID: 35505417 Free PMC article.
-
Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.Eur Urol. 2019 Jul;76(1):18-23. doi: 10.1016/j.eururo.2018.12.036. Epub 2019 Jan 24. Eur Urol. 2019. PMID: 30685078 Free PMC article.
-
The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa).Curr Urol Rep. 2019 Sep 2;20(10):60. doi: 10.1007/s11934-019-0926-0. Curr Urol Rep. 2019. PMID: 31478113 Review.
-
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.Eur Urol Open Sci. 2020 Jul;20:37-47. doi: 10.1016/j.euros.2020.06.006. Eur Urol Open Sci. 2020. PMID: 33000006 Free PMC article. Review.
Cited by
-
NIR laser-activated phthalocyanine loaded lipid nanoparticles targeting M2 macrophage for improved photoacoustic imaging-guided photothermal therapy.Mater Today Bio. 2024 Aug 24;28:101209. doi: 10.1016/j.mtbio.2024.101209. eCollection 2024 Oct. Mater Today Bio. 2024. PMID: 39221205 Free PMC article.
-
An Artificial Intelligence Model Using Diffusion Basis Spectrum Imaging Metrics Accurately Predicts Clinically Significant Prostate Cancer.J Urol. 2025 Jun;213(6):777-785. doi: 10.1097/JU.0000000000004456. Epub 2025 Jan 27. J Urol. 2025. PMID: 39869819
-
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy.Mil Med Res. 2024 Apr 11;11(1):21. doi: 10.1186/s40779-024-00526-7. Mil Med Res. 2024. PMID: 38605399 Free PMC article. Review.
-
Prognostic value of MR visibility/invisibility in men on Active Surveillance.Prostate Cancer Prostatic Dis. 2025 Jan 17. doi: 10.1038/s41391-024-00932-x. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 39824930
-
Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis.ACS Omega. 2023 Feb 7;8(7):6126-6138. doi: 10.1021/acsomega.2c06659. eCollection 2023 Feb 21. ACS Omega. 2023. PMID: 36844580 Free PMC article. Review.
References
-
- Kim EH, Andriole GL. Prostate-specific antigen-based screening: controversy and guidelines. BMC Med. 2015;13:61.
-
- De Visschere PJL, Vral A, Perletti G, Pattyn E, Praet M, Magri V, et al. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate. Eur Radiol. 2017;27:2095–109.
-
- Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011;197:1382–90.
-
- Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259:453–61.
-
- Zelhof B, Pickles M, Liney G, Gibbs P, Rodrigues G, Kraus S, et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int. 2009;103:883–8.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical